Healthcare | August 30, 2023
GarbhaGudi IVF Centre launches ‘Ghar Ghar Garbhagudi' campaign
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
The company has entered into a three-year Deferred Prosecution Agreement
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Subscribe To Our Newsletter & Stay Updated
